Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac vs. Bromfenac Aqueous Concentrations in Cataract Patients
NCT00347503Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in cataract comparing Ketorolac 0.4% with Bromfenac 0.09% (2 arms). Primary endpoints: Aqueous humor drug concentration and Aqueous humor Prostaglandin E2 levels. Status: completed.
02
Drugs
ketorolacbromfenac sodium
03
Conditions
cataract
Beyond the preview
Go deeper on NCT00347503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00347503.